AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionNaples Global Advisors, Llc
Latest Disclosed Ownership47,716 shares
Latest Disclosed Value $ 10,377,855
Naples Global Advisors, Llc reports 0.08% decrease in ownership of 4AB / AbbVie Inc.

On April 20, 2026 - Naples Global Advisors, Llc filed a 13F-HR form disclosing ownership of 47,716 shares of AbbVie Inc. (BG:4AB) valued at $10,377,855 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 47,756 shares of AbbVie Inc.. This represents a change in shares of -0.08% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F ABBVIE COM 00287Y109 47,716 -40 -0.08 10,378 -4.89 0.7572
2026-02-04 2025-12-31 13F ABBVIE COM 00287Y109 47,756 -581 -1.20 10,912 -2.51 0.8154
2025-10-30 2025-09-30 13F ABBVIE COM 00287Y109 48,337 1,068 2.26 11,192 27.56 0.8716
2025-07-18 2025-06-30 13F ABBVIE COM 00287Y109 47,269 -369 -0.77 8,774 -12.09 0.7550
2025-04-10 2025-03-31 13F ABBVIE COM 00287Y109 47,638 -1,135 -2.33 9,981 15.17 0.9483
2025-01-29 2024-12-31 13F ABBVIE COM 00287Y109 48,773 -169 -0.35 8,667 -10.34 0.8107
2024-10-24 2024-09-30 13F ABBVIE COM 00287Y109 48,942 -456 -0.92 9,665 14.08 0.8986
2024-07-18 2024-06-30 13F ABBVIE COM 00287Y109 49,398 -132 -0.27 8,473 -6.06 0.8502
2024-04-29 2024-03-31 13F ABBVIE COM 00287Y109 49,530 -576 -1.15 9,019 16.16 0.9233
2024-01-11 2023-12-31 13F ABBVIE COM 00287Y109 50,106 -1,478 -2.87 7,765 0.98 0.8539
2023-10-16 2023-09-30 13F ABBVIE COM 00287Y109 51,584 -717 -1.37 7,689 9.13 0.9318
2023-07-17 2023-06-30 13F ABBVIE COM 00287Y109 52,301 -318 -0.60 7,047 -15.97 0.8266
2023-04-17 2023-03-31 13F ABBVIE COM 00287Y109 52,619 -346 -0.65 8,386 -2.03 1.0455
2023-04-17 2022-12-31 13F/A-1 ABBVIE COM 00287Y109 52,965 -303 -0.57 8,560 19.72 1.0878
2023-01-20 2022-12-31 13F ABBVIE COM 00287Y109 52,965 -303 8,560 0.0011
2022-10-20 2022-09-30 13F ABBVIE COM 00287Y109 53,268 698 1.33 7,149 -11.21 0.9839
2022-08-11 2022-06-30 13F ABBVIE COM 00287Y109 52,570 934 1.81 8,052 -3.81 1.0449
2022-04-28 2022-03-31 13F ABBVIE COM 00287Y109 51,636 -95 -0.18 8,371 19.52 0.9665
2022-02-04 2021-12-31 13F ABBVIE COM 00287Y109 51,731 410 0.80 7,004 26.52 0.8117
2021-10-29 2021-09-30 13F/A-1 ABBVIE COM 00287Y109 51,321 2,053 4.17 5,536 -0.25 0.7271
2021-10-25 2021-09-30 13F ABBVIE COM 00287Y109 51,321 2,053 5,536 0.7236
2021-08-06 2021-06-30 13F ABBVIE COM 00287Y109 49,268 2,290 4.87 5,550 9.17 0.7717
2021-05-10 2021-03-31 13F ABBVIE COM 00287Y109 46,978 998 2.17 5,084 3.19 0.7727
2021-02-08 2020-12-31 13F ABBVIE COM 00287Y109 45,980 2,657 6.13 4,927 29.83 0.8331
2020-10-26 2020-09-30 13F ABBVIE COM 00287Y109 43,323 832 1.96 3,795 -9.04 0.7398
2020-08-04 2020-06-30 13F ABBVIE COM 00287Y109 42,491 1,123 2.71 4,172 32.36 0.8989
2020-04-27 2020-03-31 13F ABBVIE COM 00287Y109 41,368 2,219 5.67 3,152 -9.06 0.8261
2020-02-05 2019-12-31 13F Abbvie COM 00287Y109 39,149 1,578 4.20 3,466 21.83 0.7278
2019-10-28 2019-09-30 13F Abbvie COM 00287Y109 37,571 2,886 8.32 2,845 12.81 0.6645
2019-07-10 2019-06-30 13F Abbvie COM 00287Y109 34,685 2,454 7.61 2,522 -2.93 0.6136
2019-04-29 2019-03-31 13F Abbvie COM 00287Y109 32,231 2,636 8.91 2,598 -0.46 0.6642
2019-02-01 2018-12-31 13F Abbvie COM 00287Y109 29,595 523 1.80 2,610 -5.09 0.7429
2018-11-13 2018-09-30 13F/A-1 Abbvie COM 00287Y109 29,072 -3,829 -11.64 2,750 -9.78 0.7297
2018-11-13 2018-09-30 13F Abbvie COM 00287Y109 32,901 0 3,048
2018-07-23 2018-06-30 13F Abbvie COM 00287Y109 32,901 1,014 3.18 3,048 0.99 0.8586
2018-04-17 2018-03-31 13F Abbvie COM 00287Y109 31,887 -251 -0.78 3,018 -2.90 0.8954
2018-01-19 2017-12-31 13F Abbvie COM 00287Y109 32,138 1,159 3.74 3,108 12.90 0.9176
2017-10-16 2017-09-30 13F Abbvie COM 00287Y109 30,979 957 3.19 2,753 26.46 0.9190
2017-07-25 2017-06-30 13F Abbvie COM 00287Y109 30,022 187 0.63 2,177 11.99 0.7722
2017-04-21 2017-03-31 13F Abbvie COM 00287Y109 29,835 322 1.09 1,944 5.19 0.6977
2017-01-30 2016-12-31 13F Abbvie COM 00287Y109 29,513 -114 -0.38 1,848 -1.12 0.7195
2016-10-11 2016-09-30 13F Abbvie COM 00287Y109 29,627 1,460 5.18 1,869 7.17 0.7309
2016-07-13 2016-06-30 13F Abbvie COM 00287Y109 28,167 -439 -1.53 1,744 6.73 0.7138
2016-04-13 2016-03-31 13F Abbvie COM 00287Y109 28,606 1,178 4.29 1,634 0.55 0.6847
2016-01-25 2015-12-31 13F Abbvie COM 00287Y109 27,428 309 1.14 1,625 10.09 0.7873
2015-10-14 2015-09-30 13F Abbvie COM 00287Y109 27,119 1,420 5.53 1,476 -14.53 0.7584
2015-07-27 2015-06-30 13F Abbvie COM 00287Y109 25,699 17 0.07 1,727 14.90 0.8288
2015-04-15 2015-03-31 13F Abbvie COM 00287Y109 25,682 2,205 9.39 1,503 -2.15 0.7144
2015-01-22 2014-12-31 13F Abbvie COM 00287Y109 23,477 739 3.25 1,536 16.98 0.8125
2014-10-16 2014-09-30 13F Abbvie COM 00287Y109 22,738 368 1.65 1,313 3.96 0.7738
2014-07-14 2014-06-30 13F Abbvie COM 00287Y109 22,370 1,053 4.94 1,263 15.24 0.7489
2014-04-07 2014-03-31 13F Abbvie COM 00287Y109 21,317 2,377 12.55 1,096 9.60 0.6703
2014-01-16 2013-12-31 13F Abbvie COM 00287Y109 18,940 18,940 1,000 0.6669
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.